Blake7;
Thank you for your reply. I'd like to make somethings very clear;
1) My frustration is ONLY related to the way the directors are adopting the cone-of-silence approach. Their clear lack of appreciation for PR, and their demonstrated disrespect for share holders, their support and most important their money. Not to mention the fact that they are able to get away with it.
Some of the information they are deliberately not releasing is related to implant rate in trials and sales. I can understand them wanting to protect their IP, but someone needs to explain to me why this market sensitive information is not being release, particularly when they are legally obligated to report on it?????!!!!!!!.....How can they justify that this information in any way, shape or form, compromises their IP?????????
That, for lack of better word, is the source of my only frustration!!!!!
I understand your point of view that you support the way the company is being run. That's fine, that's your view, I respect that. But don't agree with it.
2) My surprise, is related to how many people constantly seem to find an execuse for the sp dropping. And my bigger surprise, is when they find any justification to buy at a lower price, just because it touched a "support level".
3) My amazement is related to how many people seem to put importance on trials and technology, and not the fundamental, WHCIH DRIVE THE MARKET. BTT and DT trials are locked-in revenue. The market has factored those in and will only pay the right price when they see these implants being carried out. Information the board is DELIBERATELY not releasing!!!!
So, people holding on for the sp to move on DT approval will be sadly disappointed imo. Because the market has factored that in and will only pay that value when they see it happen!!!!.........Again, information that is not being released by the F*&^%$G incompetent board.
What will really get the SP to move (to the level people dream of), is actual sales. Again, current sales that the board is not releasing information on!!!!!.......The market will really start to pay for this stock, when the FDA approval is obtained for BTT. Because then, that gives VCR the access to the untapped market without any constraints.
The market knows of the efficacy of the device. Using it for BTT and keeping the patient on it for a long time (because it works), is just a pseudonym for DT without the paper work!!!!!!!............That, imo, is what the market is waiting for.
So according to VCR's lated press release, this should be happening around late 2008 to start of 2009. And people still say 2007 will be a good year for VCR!!!!...and continually justify price drops!!!!!!!!............Amazing!!!!!
Cheers, and thanks for your response.
VCR
ventracor limited
